bioAffinity Technologies (BIAF) Other Accumulated Expenses (2021 - 2026)
bioAffinity Technologies (BIAF) posted quarterly Other Accumulated Expenses of $23630.0 for Q1 2026, down 46.54% year-over-year from $44205.0 in Q1 2025, and down 2.1% quarter-over-quarter from $24138.0 in Q4 2025.
bioAffinity Technologies (BIAF) Other Accumulated Expenses (2021 - 2026) Analysis & Trends
bioAffinity Technologies (BIAF) has reported Other Accumulated Expenses for 6 consecutive years, with $23630.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Other Accumulated Expenses fell 46.54% year-over-year to $23630.0; the TTM figure through Mar 2026 stood at $23630.0 (down 46.54% YoY), while the FY2025 annual figure was $24138.0, down 59.79% from the prior year.
- Other Accumulated Expenses retreated to $23630.0 in Q1 2026 per BIAF's latest filing, from $24138.0 in the prior quarter.
- Across five years, Other Accumulated Expenses topped out at $112590.0 in Q2 2025 and bottomed at $1751.0 in Q2 2024.
- Historically, Other Accumulated Expenses has averaged $28286.6 across 5 years, with a median of $21564.0 in 2023.
- Annual changes were most pronounced in 2024 — Other Accumulated Expenses sank 64.98% — and 2025, when it surged 6330.04%.
- bioAffinity Technologies' Other Accumulated Expenses stood at $5852.0 in 2022, then jumped by 233.19% to $19498.0 in 2023, then soared by 207.9% to $60035.0 in 2024, then plunged by 59.79% to $24138.0 in 2025, then retreated by 2.1% to $23630.0 in 2026.
- Business Quant data shows BIAF's Other Accumulated Expenses at $23630.0 in Q1 2026, $24138.0 in Q4 2025, and $28658.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn |
| 10 | bioAffinity Technologies | 2.38 Mn | -721,990.64 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 23,630.00 |
| Dec 31, 2025 | 24,138.00 |
| Sep 30, 2025 | 28,658.00 |
| Jun 30, 2025 | 112,590.00 |
| Mar 31, 2025 | 44,205.00 |
| Dec 31, 2024 | 60,035.00 |
| Sep 30, 2024 | 43,311.00 |
| Jun 30, 2024 | 1,751.00 |
| Mar 31, 2024 | 12,922.00 |
| Dec 31, 2023 | 19,498.00 |
| Jun 30, 2023 | 5,000.00 |
| Mar 31, 2023 | 10,170.00 |
| Dec 31, 2022 | 5,852.00 |
| Sep 30, 2022 | 4,253.00 |
| Dec 31, 2021 | 766.00 |